OT ULTRAMINI METER
Report
- Report Number
- 3008382007-2016-63658
- Event Type
- Injury
- Date Received
- December 12, 2016
- Report Date
- December 2, 2016
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- PMA / PMN Number
- K061118
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PATIENT
Narratives
THE LAY USER/PATIENTS METER HAS BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE METER PASSED ALL TESTING WITH NO FAULTS FOUND. THE REPORTED ISSUE COULD NOT BE CONFIRMED. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.
ON (B)(6) 2016 THE REPORTER CONTACTED LIFESCAN ALLEGING THAT THE PATIENT¿S ONETOUCH ULTRAMINI METER WAS READING INACCURATELY HIGH. THE FOLLOWING COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED FROM THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE REPORTER ALLEGED THAT THE PRODUCT ISSUE BEGAN IN (B)(6) 2016. THE PATIENT MANAGES THEIR DIABETES WITH A COMBINATION OF MEDICATION, INCLUDING METFORMIN, HUMALOG AND LANTUS. THE REPORTER STATED THAT THE PATIENT CONTINUED TO TAKE THEIR USUAL DOSE OF MEDICATION IN RESPONSE TO THE ALLEGED ISSUE. THE REPORTER STATED THAT AT 3PM ON (B)(6) 2016 THE LAY USER/PATIENT DEVELOPED SYMPTOMS OF ¿DISORIENTATION, STUTTERING, SHAKING AND COULD NOT SAY A FULL SENTENCE¿. THE REPORTER STATED THAT THEY CALLED 911 AND EMERGENCY MEDICAL SERVICES (EMS) CAME TO THE PATIENT¿S HOME. THE REPORTER STATED THAT THE PATIENT RECEIVED HCP TREATMENT BUT THEY WERE UNABLE TO PROVIDE FURTHER DETAILS. THE REPORTER STATED THAT THE EMS OBTAINED A BLOOD GLUCOSE READING OF 42MG/DL. THE REPORTER ALLEGED MULTIPLE INACCURACIES ON THE SUBJECT METER AFTER THE PATIENT DEVELOPED THE REPORTED SYMPTOMS. THE REPORTER STATED THAT THE PATIENT OBTAINED A BLOOD GLUCOSE READING OF 180MG/DL ON THE SUBJECT METER AND 130MG/DL ON A ONETOUCH ULTRA2 METER, OBTAINED WITHIN 30 MINUTES OF EACH OTHER. THE REPORTER ALSO STATED THAT THE PATIENT OBTAINED BLOOD GLUCOSE READINGS OF 227, 180, 295, 230, 221 AND 249MG/DL ON THE SUBJECT METER AND ALLEGED THAT THEY WERE INACCURATELY HIGH COMPARED TO THE PATIENT¿S NORMAL READINGS AND/OR FEELINGS. THE REPORTER ALSO STATED THAT THE PATIENT OBTAINED A BLOOD GLUCOSE READING OF 69MG/DL ON THE SUBJECT METER AND 42MG/DL ON AN EMS METER, OBTAINED WITHIN 30 MINUTES OF EACH OTHER. BASED ON STATISTICAL METHODOLOGY THESE READINGS EXCEED LIFESCAN¿S CRITERIA FOR ACCURACY. AT THE TIME OF TROUBLESHOOTING THE CCA NOTED THAT THE SUBJECT METER HAD RECENTLY PASSED A CONTROL SOLUTION TEST; HOWEVER, THE REPORTER DIDNOT HAVE ANY TEST STRIPS LEFT TO REPEAT THIS TEST. THE CCA ALSO NOTED THAT THE PATIENT WAS FACING AN ISSUE WITH THE DATE/TIME SETTINGS AND THE METER DID NOT REVERT TO SET UP MODE WHEN THE BATTERY WAS CHANGED. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DEVELOPED SIGNS AND/OR SYMPTOMS THAT MEET LIFESCAN¿S CRITERIA FOR A SERIOUS INJURY REPORTABLE ADVERSE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 817201 | OT ULTRAMINI METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Life Threatening| R |